Clinical Trial Update: A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of cetuximab with cisplatin and capecitabine as first-line therapy for advanced gastric cancer has completed. The snippet provides trial status bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Cetuximab (cetuximab)

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED